Two Buyout Firms Vie For Patch Maker LTS Lohmann Therapie-Systeme AG -Sources

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

The bidding for German medical skin patch maker LTS Lohmann has turned into a two-way race between buyout firms Wendel and Nordic Capital, valuing the company at about 1.2 billion euros ($1.6 billion), three people familiar with the matter said. Nordic Capital may be looking to combine LTS Lohmann with another skin patch maker it agreed to buy last month, Acino . Nordic had teamed up with Avista Capital Partners to acquire the Swiss firm, which makes a contraceptive patch for Bayer.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC